Near-infrared Optical Imaging of Exposed Phosphatidylserine in a Mouse Glioma Model

Dawen Zhao, Jason H. Stafford, Heling Zhou, Philip E. Thorpe

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Phosphatidylserine (PS) is normally intracellular but becomes exposed on the luminal surface of vascular endothelial cells in tumors. It also becomes exposed on tumors cells responding to therapy. In the present study, we optically imaged exposed PS in vivo using PGN635, a novel monoclonal antibody that binds PS. The F(ab′)2 fragment of PGN635 was labeled with the near-infrared (NIR) dye, IRDye800CW. In vivo dynamic NIR imaging was performed after injection of 800CW-PGN635 into mice bearing radiation-treated or untreated U87 glioma xenografts growing subcutaneously or orthotopically. NIR optical imaging revealed a clear tumor contrast in nonirradiated subcutaneous U87 gliomas after injection of 800CW-PGN635. The tumor contrast was visible as early as 4 hours later and was maximal 24 hours later (tumor-to-normal tissue ratio [TNR] = 2.8 ± 0.7). Irradiation enhanced the tumor contrast at 24 hours (TNR = 4.0 ± 0.3). Similar results were observed for orthotopic gliomas. Localization of 800CW-PGN635 to tumors was antigen specific because 800CW-Aurexis, a control probe of irrelevant specificity, did not localize to the tumors, and preadministration of unlabeled PGN635 blocked the uptake of 800CW-PGN635. Fluorescence microscopy confirmed that 800CW-PGN635 was binding to PS-positive vascular endothelial cells in nonirradiated gliomas. Irradiation of the gliomas increased PS exposure on both tumor vascular endothelial cells and tumor cells and gave rise to an increase in tumor contrast with 800CW-PGN635 that was predictive of the reduction in tumor growth. 800CWPGN635 may be a useful new imaging probe for detection of exposed PS in tumors responding to therapy.

Original languageEnglish (US)
Pages (from-to)355-364
Number of pages10
JournalTranslational Oncology
Volume4
Issue number6
DOIs
StatePublished - Dec 2011

Fingerprint

Optical Imaging
Phosphatidylserines
Glioma
Neoplasms
Endothelial Cells
Injections
Neoplasm Antigens
Fluorescence Microscopy
Heterografts
Coloring Agents
Monoclonal Antibodies
Radiation

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Near-infrared Optical Imaging of Exposed Phosphatidylserine in a Mouse Glioma Model. / Zhao, Dawen; Stafford, Jason H.; Zhou, Heling; Thorpe, Philip E.

In: Translational Oncology, Vol. 4, No. 6, 12.2011, p. 355-364.

Research output: Contribution to journalArticle

Zhao, Dawen ; Stafford, Jason H. ; Zhou, Heling ; Thorpe, Philip E. / Near-infrared Optical Imaging of Exposed Phosphatidylserine in a Mouse Glioma Model. In: Translational Oncology. 2011 ; Vol. 4, No. 6. pp. 355-364.
@article{5c8c1dfd5d4e4ecc85e71fcfe4546d2d,
title = "Near-infrared Optical Imaging of Exposed Phosphatidylserine in a Mouse Glioma Model",
abstract = "Phosphatidylserine (PS) is normally intracellular but becomes exposed on the luminal surface of vascular endothelial cells in tumors. It also becomes exposed on tumors cells responding to therapy. In the present study, we optically imaged exposed PS in vivo using PGN635, a novel monoclonal antibody that binds PS. The F(ab′)2 fragment of PGN635 was labeled with the near-infrared (NIR) dye, IRDye800CW. In vivo dynamic NIR imaging was performed after injection of 800CW-PGN635 into mice bearing radiation-treated or untreated U87 glioma xenografts growing subcutaneously or orthotopically. NIR optical imaging revealed a clear tumor contrast in nonirradiated subcutaneous U87 gliomas after injection of 800CW-PGN635. The tumor contrast was visible as early as 4 hours later and was maximal 24 hours later (tumor-to-normal tissue ratio [TNR] = 2.8 ± 0.7). Irradiation enhanced the tumor contrast at 24 hours (TNR = 4.0 ± 0.3). Similar results were observed for orthotopic gliomas. Localization of 800CW-PGN635 to tumors was antigen specific because 800CW-Aurexis, a control probe of irrelevant specificity, did not localize to the tumors, and preadministration of unlabeled PGN635 blocked the uptake of 800CW-PGN635. Fluorescence microscopy confirmed that 800CW-PGN635 was binding to PS-positive vascular endothelial cells in nonirradiated gliomas. Irradiation of the gliomas increased PS exposure on both tumor vascular endothelial cells and tumor cells and gave rise to an increase in tumor contrast with 800CW-PGN635 that was predictive of the reduction in tumor growth. 800CWPGN635 may be a useful new imaging probe for detection of exposed PS in tumors responding to therapy.",
author = "Dawen Zhao and Stafford, {Jason H.} and Heling Zhou and Thorpe, {Philip E.}",
year = "2011",
month = "12",
doi = "10.1593/tlo.11178",
language = "English (US)",
volume = "4",
pages = "355--364",
journal = "Translational Oncology",
issn = "1936-5233",
publisher = "Neoplasia Press",
number = "6",

}

TY - JOUR

T1 - Near-infrared Optical Imaging of Exposed Phosphatidylserine in a Mouse Glioma Model

AU - Zhao, Dawen

AU - Stafford, Jason H.

AU - Zhou, Heling

AU - Thorpe, Philip E.

PY - 2011/12

Y1 - 2011/12

N2 - Phosphatidylserine (PS) is normally intracellular but becomes exposed on the luminal surface of vascular endothelial cells in tumors. It also becomes exposed on tumors cells responding to therapy. In the present study, we optically imaged exposed PS in vivo using PGN635, a novel monoclonal antibody that binds PS. The F(ab′)2 fragment of PGN635 was labeled with the near-infrared (NIR) dye, IRDye800CW. In vivo dynamic NIR imaging was performed after injection of 800CW-PGN635 into mice bearing radiation-treated or untreated U87 glioma xenografts growing subcutaneously or orthotopically. NIR optical imaging revealed a clear tumor contrast in nonirradiated subcutaneous U87 gliomas after injection of 800CW-PGN635. The tumor contrast was visible as early as 4 hours later and was maximal 24 hours later (tumor-to-normal tissue ratio [TNR] = 2.8 ± 0.7). Irradiation enhanced the tumor contrast at 24 hours (TNR = 4.0 ± 0.3). Similar results were observed for orthotopic gliomas. Localization of 800CW-PGN635 to tumors was antigen specific because 800CW-Aurexis, a control probe of irrelevant specificity, did not localize to the tumors, and preadministration of unlabeled PGN635 blocked the uptake of 800CW-PGN635. Fluorescence microscopy confirmed that 800CW-PGN635 was binding to PS-positive vascular endothelial cells in nonirradiated gliomas. Irradiation of the gliomas increased PS exposure on both tumor vascular endothelial cells and tumor cells and gave rise to an increase in tumor contrast with 800CW-PGN635 that was predictive of the reduction in tumor growth. 800CWPGN635 may be a useful new imaging probe for detection of exposed PS in tumors responding to therapy.

AB - Phosphatidylserine (PS) is normally intracellular but becomes exposed on the luminal surface of vascular endothelial cells in tumors. It also becomes exposed on tumors cells responding to therapy. In the present study, we optically imaged exposed PS in vivo using PGN635, a novel monoclonal antibody that binds PS. The F(ab′)2 fragment of PGN635 was labeled with the near-infrared (NIR) dye, IRDye800CW. In vivo dynamic NIR imaging was performed after injection of 800CW-PGN635 into mice bearing radiation-treated or untreated U87 glioma xenografts growing subcutaneously or orthotopically. NIR optical imaging revealed a clear tumor contrast in nonirradiated subcutaneous U87 gliomas after injection of 800CW-PGN635. The tumor contrast was visible as early as 4 hours later and was maximal 24 hours later (tumor-to-normal tissue ratio [TNR] = 2.8 ± 0.7). Irradiation enhanced the tumor contrast at 24 hours (TNR = 4.0 ± 0.3). Similar results were observed for orthotopic gliomas. Localization of 800CW-PGN635 to tumors was antigen specific because 800CW-Aurexis, a control probe of irrelevant specificity, did not localize to the tumors, and preadministration of unlabeled PGN635 blocked the uptake of 800CW-PGN635. Fluorescence microscopy confirmed that 800CW-PGN635 was binding to PS-positive vascular endothelial cells in nonirradiated gliomas. Irradiation of the gliomas increased PS exposure on both tumor vascular endothelial cells and tumor cells and gave rise to an increase in tumor contrast with 800CW-PGN635 that was predictive of the reduction in tumor growth. 800CWPGN635 may be a useful new imaging probe for detection of exposed PS in tumors responding to therapy.

UR - http://www.scopus.com/inward/record.url?scp=82855176765&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=82855176765&partnerID=8YFLogxK

U2 - 10.1593/tlo.11178

DO - 10.1593/tlo.11178

M3 - Article

VL - 4

SP - 355

EP - 364

JO - Translational Oncology

JF - Translational Oncology

SN - 1936-5233

IS - 6

ER -